医学
骨质疏松症
特立帕肽
德诺苏马布
雷洛昔芬
选择性雌激素受体调节剂
内科学
儿科
物理疗法
骨矿物
重症监护医学
雌激素受体
乳腺癌
癌症
作者
C. Bree Johnston,Meenakshi Dagar
标识
DOI:10.1016/j.mcna.2020.06.004
摘要
Osteoporosis and osteoporosis-related fractures are common causes of morbidity and mortality in older adults. Healthy adults should be counseled about measures to prevent osteoporosis. Women should be screened for osteoporosis beginning at age 65. Screening for osteoporosis in men should be considered when risk factors are present. Appropriate screening intervals are controversial. Women and men with osteoporosis should be offered pharmacologic therapy. Choice of therapy should be based on safety, cost, convenience, and other patient-related factors. Bisphosphonates are a first-line therapy for many patients with osteoporosis. Other treatments for osteoporosis include denosumab, teriparatide, abaloparatide, romosozumab, and selective estrogen receptor modulators.
科研通智能强力驱动
Strongly Powered by AbleSci AI